To prepare us for future pandemics, researchers at the Helmholtz Institute for One Health (HIOH) not only look at the pathogens, but also at how changes in the environment and nature - including those caused by us -...
Bacteria are a valuable source for the discovery of natural products that can be used for the development of new drugs. A HIPS research team has now identified two new classes of active substances with antimicrobial...
So-called high-dose flu vaccines are available for older people. The reason: their immune system does not always respond sufficiently well to the standard flu vaccines. Why this is the case and the molecular processes...
What opportunities lie ahead for the future of medical research and healthcare systems? Researchers from the Helmholtz Association exchange ideas with decision-makers from science, politics, patient organizations,...
The intestinal microbiome is currently the subject of intensive research, as it is of great importance for human health. Intestinal bacteria play an essential role in the defense against dangerous pathogens, which is...
Colistin is a last-resort antibiotic that is usually only used for severe infections with resistant bacteria. This is due to its severe kidney-damaging side effects, which occur in around 30 percent of treated patients....
Microorganisms do not just colonize the body of mammals during infections. Billions of microbes can be found on and in healthy humans and animals at any given time, communicating with each other via chemical signals and...
Prof. Josef Penninger, Scientific Director of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, has been appointed honorary professor of the Faculty of Life Sciences at Technische Universität...
The Helmholtz Centre for Infection Research (HZI) and the Friends of the HZI are presenting the first event in the Vienna “Sounds and Science” series in cooperation with the Staatstheater Braunschweig. A string quartet...
